Ads
related to: uterine sarcoma vs endometrial carcinoma ihc survival rate symptoms- Research Design & Data
Discover Eligibility Criteria &
Baseline Patient Characteristics.
- Request A Representative
Get More Info About A Now Approved
Treatment Option For HR+ HER2- mBC.
- Care Team Corner
Comprehensive Resources To Support
Your Patients. Learn More Here.
- Dosing & Administration
See Dosing Regimen & Preparation
Info For A New Treatment Option
- Research Design & Data
Search results
Results From The WOW.Com Content Network
If cancer has spread beyond the uterus, radiation, chemotherapy, and hormonal therapy may be used. If detected in its early stages, survival rates for uterine sarcoma are 66% after 5 years. If cancer has spread beyond the uterus, the survival rate declines to approximately 13-34%. [1]
Symptoms: Endometrial cancer: vaginal bleeding, pelvic pain [1] Uterine sarcoma: vaginal bleeding, mass in the vagina [2] Types: Endometrial cancer, uterine sarcoma [3] Risk factors: Endometrial cancer: obesity, metabolic syndrome, type 2 diabetes, tamoxifen use, unopposed estrogens, late menopause, family history of the condition [1]
As with endometrial carcinomas, the prognosis is influenced by the grade and type of the adenocarcinoma, being poorest with serous differentiation. MMMTs are highly malignant; a stage I tumor has an expected five-year survival rate of 50%, while the overall five-year survival rate is less than 20%. [1] Staging of uterine MMMTs is as follows: [3]
Endometrial cancer is sometimes called "uterine cancer", although it is distinct from other forms of cancer of the uterus such as cervical cancer, uterine sarcoma, and trophoblastic disease. [9] The most frequent type of endometrial cancer is endometrioid carcinoma, which accounts for more than 80% of cases. [3]
Uterine serous carcinoma is a malignant form of serous tumor that originates in the uterus. It is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is typically diagnosed on endometrial biopsy , prompted by post-menopausal bleeding .
The most common cancer among women in the United States is breast cancer (123.7 per 100,000), followed by lung cancer (51.5 per 100,000) and colorectal cancer (33.6 per 100,000), but lung cancer surpasses breast cancer as the leading cause of cancer death among women. [13]